Before revision: A newer PCAB Vonoprazan with a faster and longer lasting action than PPIs has been marketed in Japan , Russia , and in 2023 the US.
After revision: A newer PCAB Vonoprazan with a faster and longer lasting action than PPIs has been marketed in Japan (2013), Russia (2021)Revaprazan, and , and in 2023 the US.